TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study.

Andrew B Lassman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.